**Core Concept**
The question is testing the student's knowledge of potassium channel openers, a class of drugs that activate potassium channels, leading to increased potassium efflux from the cell. This results in a decrease in the resting membrane potential, which in turn causes vasodilation and a decrease in blood pressure.

**Why the Correct Answer is Right**
The correct answer is a specific type of potassium channel opener that acts on ATP-sensitive potassium channels. These channels are activated when intracellular ATP levels are low, leading to the closure of potassium channels. However, the correct answer opens these channels, allowing potassium to flow out of the cell and leading to vasodilation. This is particularly useful in the treatment of conditions such as angina pectoris and hypertension.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is a calcium channel blocker, which works by inhibiting the influx of calcium ions into the cell, rather than opening potassium channels.
**Option B:** This option is incorrect because it is a beta blocker, which works by inhibiting the effects of catecholamines such as adrenaline and noradrenaline, rather than opening potassium channels.
**Option C:** This option is incorrect because it is an alpha blocker, which works by inhibiting the effects of alpha-adrenergic receptors, rather than opening potassium channels.

**Clinical Pearl / High-Yield Fact**
Potassium channel openers are particularly useful in the treatment of angina pectoris because they allow for vasodilation without the negative inotropic effects of calcium channel blockers. Additionally, they are often used in combination with other medications to enhance their effects.

**Correct Answer:** C. Pinacidil